Key Players and Competitive Dynamics in the Blockchain in Genomics Market

The blockchain technology revolution is making significant strides in genomics, offering new ways to secure, share, and manage genetic data. As the fusion of blockchain and genomics advances, the market is poised for remarkable growth, driven by innovations that promise enhanced data privacy and novel business models. Let's explore the current market outlook, key players, emerging trends, and segmentation within this exciting sector.

Forecasted Market Expansion in Blockchain in Genomics by 2030
The blockchain in genomics market is projected to experience substantial growth, reaching a value of $2.35 billion by 2030. This expansion corresponds to a strong compound annual growth rate (CAGR) of 18.3%. Several factors underpin this rapid growth, including the integration of blockchain technology with artificial intelligence in genomics, the development of genomic data marketplaces, and the increasing adoption of tokenized genomic data models. Additionally, the rise of both business-to-business (B2B) and business-to-consumer (B2C) genomic services, alongside heightened regulatory attention on data privacy and security, is propelling market advancement. Key trends expected to dominate the forecast period include secure storage solutions for genomic data, blockchain-facilitated genomic data sharing, patient consent management via blockchain, automated control over genomic data access, and the tokenization of genomic information.

Download a free sample of the blockchain in genomics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13814&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR

Primary Companies Leading the Blockchain in Genomics Market
The blockchain in genomics industry features several prominent players that are shaping its landscape. These include International Business Machines Corporation, Sharecare Inc., WuXi Nextcode Genomics Inc., Health Utility Network Inc., Medicalchain Ltd., Futura Genetics LLC, Nebula Genomics Inc., Digital DNAtix Ltd., EncrypGen Inc., Longenesis, Guardtime AS, Embleema Inc., Patientory Inc., Shivom Ventures Limited, BurstIQ LLC, Genobank.io Inc., LunaDNA LLC, SimplyVital Health Inc., and Zenome.io Ltd.

Noteworthy Partnership Enhancing Blockchain Applications in Genomics
In May 2024, Rymedi, a US-based firm specializing in blockchain-enabled healthcare data management platforms, announced a collaboration with Precision Genetics. This partnership aims to improve healthcare outcomes by integrating Precision Genetics' personalized drug response solution with Rymedi's blockchain-powered clinical trial platform. The joint effort seeks to minimize post-surgical drug risks and enhance recovery processes, thereby modernizing patient care and boosting overall healthcare efficiency. Precision Genetics is recognized for its expertise in genomic testing and precision medicine within the United States.

View the full blockchain in genomics market report:
https://www.thebusinessresearchcompany.com/report/blockchain-in-genomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR

Emerging Trends Highlighting Innovations in Blockchain for Genomics
Leading companies are forming strategic alliances to develop blockchain-based Proof of Personhood (PoP) credentials that utilize DNA testing for secure and sybil-resistant identity verification. A prime example occurred in February 2025 when Humanity Protocol, a blockchain identity verification network based in China, partnered with Prenetics, a Chinese genomics company. This collaboration integrated Prenetics' CircleDNA service as an official Identity Validator within Humanity Protocol's blockchain framework. By combining advanced genetic testing with zero-knowledge proof technology, they are working to create privacy-preserving PoP credentials designed to prevent Sybil attacks.

Investment and Future Vision in Blockchain and Genomics Innovation
Beyond identity verification, Prenetics is building a Crypto Strategic Reserve with a $1.5 million investment in digital assets such as $H tokens, Bitcoin, and Solana. This move supports ongoing innovation at the intersection of blockchain, healthcare, and decentralized science. The partnership's goal is to merge genomic precision with blockchain capabilities to facilitate decentralized identity solutions across finance, healthcare, and governance sectors, all while maintaining rigorous privacy standards. This initiative represents a major leap forward in integrating DNA-based identity verification into the Web3 and decentralized technology ecosystems.

Detailed Segmentation Within the Global Blockchain in Genomics Market
The blockchain in genomics market is segmented across several dimensions:

1) By Service Type:
- Utility Tokens
- Blockchain Platforms

2) By Business Model:
- Business-to-Business (B2B)
- Business-to-Consumer (B2C)
- Consumer-to-Business (C2B)

3) By Application:
- Automated Health Insurance
- Pharmaceutical and Biotechnology Companies
- Hospitals and Healthcare Providers
- Research Institutes
- Data Owners
- Other Applications

Further subcategories include:
- Utility Tokens divided into Access Tokens and Functional Tokens
- Blockchain Platforms classified as Public, Private, and Consortium Blockchain Platforms

This segmentation provides a comprehensive framework to understand the various facets of the blockchain in genomics market and its diverse applications worldwide.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.